摘要 |
<p>The present invention relates to the cloning of βAPP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of β-APP involved in Alzheimer's Disease.</p> |